Neonatal hepatoblastoma: a report of 8 cases with a literature review

Gongbao Liu,Baihui Liu,Yangyang Ma,Kai Li,Kuiran Dong

DOI: https://doi.org/10.3760/cma.j.issn.0253-3006.2015.04.007

2015-01-01

Abstract:Objective To summarize the clinical manifestations and outcomes of neonatal hepatoblastoma for its improved recognization and more effective treatment.Methods For this retrospective study,8 patients with neonatal hepotoblastoma were admitted from 2007 to 2014.Only neonates and infants aged under 2 months with adequate clinicopathologic data were accepted for review.There were 6 boys and 2 girls with a mean diagnostic age of 24.75 ± 17.62 (2-50) days.The mean birth weight at diagnosis was 3.42 ± 0.47 (2.6-4.0) kg.Seven tumors were derived from right hepatic lobe while another from left hepatic lobe.According to the criteria of PRETEXT,the stages were Ⅰ (n =1),Ⅱ (n =1) and Ⅲ (n =6).According to the histology classification,all tumors were of epithelial type.One patient was of pure fetal histology subtype while the remainder mixed fetal & embryonal subtype.Patients with stages Ⅰ and Ⅱ underwent primary operation while those with stage Ⅲ open biopsy and neoadjuvant chemotherapy.Five patients had delayed operation.The mean interval of preoperative chemotherapy was 4.17 ± 1.16 cycles,median 4 cycles.The mean time of initiating postoperative chemotherapy was 22.00 ± 9.42 days,median 23.5 days.The mean interval of postoperative chemotherapy was 5.00 ± 2.52 cycles,median 4.5cycles.Results Right hepatic duct was injured and subsequently repaired with cholangio-jejunostomy in 1 case.There were no other complications.Two tumors recurred postoperatively.Another 5 patients survived tumor-free.The median period of follow-up was 29.5 months.The 2,5-year overall survivals were 75％ and 60％ respectively.Conclusions Normal term newborns with hepatoblastoma have a good prognosis after standard treatments.Neonatal hepatoblastoma is rare so that it is necessary to conduct a multicenter and multidisciplinary study.